OncoSec Medical Raises $42M In Public Offering
socalTECH
JANUARY 21, 2021
San Diego- and New Jersey-based OncoSec Medical, a publicly traded biotechnology company focused on treatment of cancer, said today that it is raising $42.0M in a public offering of its common stock. The company said it is offering of 7,711,284 shares of its common stock at a price of $5.45, with an expected close on January 25th. The company said the new funds will go towards clinical, regulatory, manufacturing and, if and when approved, potential commercial activities of its product candidates
Let's personalize your content